Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Switch-associated protein 70 (SWAP-70) is a multifunctional protein that acts as a phosphatidylinositol 3,4,5-trisphosphate (PIP3)-dependent guanine nucleotide exchange factor (GEF) and a unique F-actin bundling protein (UniProt Q9UH65; PubMed 10681448, 23921380). It is primarily expressed in hematopoietic cells, where it plays a pivotal role in B-cell isotype switching, dendritic cell migration, and mast cell activation (PubMed 11929948, 21307294). SWAP-70 facilitates the reorganization of the actin cytoskeleton by tethering F-actin to the plasma membrane and stabilizing activated Rac1, which is essential for processes like lamellipodia formation, phagocytosis, and cell motility (PubMed 28489960, 31932501). In the context of disease, SWAP-70 is recognized as a potential oncogene and a promoter of tumor metastasis; its overexpression or mutation enhances the invasive and migratory capabilities of cancer cells in breast, lung, and ovarian cancers (PubMed 23555004, 38755184). Conversely, in the cardiovascular system, SWAP-70 exerts a protective effect against pathological cardiac hypertrophy by inhibiting the TAK1 signaling pathway (PubMed 36974738). While specific clinical drugs targeting SWAP-70 are not yet approved, small molecules like sanguinarine have been identified as putative inhibitors, and its role in metastasis and inflammation makes it a compelling target for future therapeutic development (PubMed 28489960).
Sanguinarine acts as a putative inhibitor that blocks SWAP-70-mediated F-actin polymerization and phagocytosis. 12(S)-HETE modulates SWAP-70 by inducing its translocation to membrane ruffles where it dimerizes and bundles actin to promote cell motility.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Switch-associated protein 70 (SWAP-70).